Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Challes-les-eaux

3 clinical trials in Challes-les-eaux, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Challes-les-eaux at a glance
3
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Challes-les-eaux

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Bortezomib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Challes-les-eaux

What the registry says about research in the country

01 Breast Cancer Research

Innovative clinical trials focusing on ER+/HER2- metastatic breast cancer are exploring combination therapies. Research evaluates the effectiveness of palbociclib combined with endocrine therapy, with particular attention to monitoring treatment responses through circulating tumor DNA analysis.

  • Hormone Therapy Optimization
  • Mutation Detection
  • Treatment Safety Assessment

These studies aim to improve treatment strategies by identifying early markers of disease progression and optimizing therapeutic combinations.

02 Multiple Myeloma Studies

Advanced research in multiple myeloma treatment focuses on elderly patients who are transplant-ineligible. The studies examine the effectiveness of Isatuximab combined with Lenalidomide and Dexamethasone, with particular attention to minimal residual disease outcomes.

  • Elderly Patient Care
  • Novel Drug Combinations
  • Disease Response Monitoring

This research specifically targets patients aged 65 to 80 years, aiming to establish optimal treatment protocols for this demographic.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.